In a retrospective cohort study on 2456 patients with at least one primary or secondary HF diagnosis during hospitalization or ER visit, NT-proBNP levels ≥411 pg/mL (median value) were not associated with higher risks for ischemic stroke and MI. This evidence concerns the gene NPPB and ischemic stroke.